Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA)

A Mangera, KE Andersson, A Apostolidis, C Chapple… - European urology, 2011 - Elsevier
CONTEXT: The use of botulinum toxin A (BoNTA) in the treatment of lower urinary tract
dysfunction has expanded in recent years and the off-licence usage list includes neurogenic …

The use of botulinum toxin for the treatment of overactive bladder syndrome

B Orasanu, ST Mahajan - Indian Journal of Urology, 2013 - journals.lww.com
Over the last 50 years, botulinum toxin has been transformed from a cause of life-threatening
disease to an effective medical therapy. It has been used in a variety of specialties for …

Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two …

P Grise, A Ruffion, P Denys, G Egon, EC Kastler - European urology, 2010 - Elsevier
BACKGROUND: Botulinum toxin type A (BoNTA) has been reported to be effective for
treatment of patients with neurogenic detrusor overactivity (NDO) refractory to anticholinergic …

Is repeat Botulinum Toxin A injection valuable for neurogenic detrusor overactivity—A systematic review and meta‐analysis

J Ni, X Wang, N Cao, J Si, B Gu - Neurourology and …, 2018 - Wiley Online Library
Aim To investigate the value of repeat botulinum toxin A (BTX‐A) injections in patients with
neurogenic detrusor overactivity (NDO). Methods We searched the PubMed, EMBASE, and …

Urodynamic outcomes in children after single and multiple injections for overactive and low compliance neurogenic bladder treated with abobotulinum toxin A

S Naqvi, J Clothier, A Wright, M Garriboli - The Journal of urology, 2020 - auajournals.org
Purpose: Intradetrusor botulinum toxin is an established part of the treatment pathway for
pediatric patients with neurogenic bladder. We determined the urodynamic effect of single …

Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity

C Dowson, MS Khan, P Dasgupta, A Sahai - Nature Reviews Urology, 2010 - nature.com
Intravesical injections of botulinum toxin-A have become established as an effective therapy
in the management of neurogenic and idiopathic detrusor overactivity that is refractory to …

Intravesical instillation of botulinum toxin A: an in vivo murine study and pilot clinical trial

J Krhut, P Zvara - International urology and nephrology, 2011 - Springer
Aim The objectives of this study were to compare the urodynamic effects of botulinum toxin A
(BoNT-A) delivered via intramural injection into the bladder wall to that of intravesical …

Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB

L Brubaker, A Gousse, P Sand, C Thompson… - International …, 2012 - Springer
Introduction and hypothesis Clinically meaningful overactive bladder syndrome (OAB)
symptom relief is associated with patient satisfaction. This study evaluated the effects of …

Botulinum A toxin as a treatment for overactive rectum with associated faecal incontinence

V Bridoux, G Gourcerol, B Kianifard… - Colorectal …, 2012 - Wiley Online Library
Aim Rectal hypercontractility can lead to faecal incontinence (FI). Botulinum toxin (BT) has
been used successfully for the treatment of bladder overactivity. This study aimed to …

Efficacy and safety of the first and repeated intradetrusor injections of abobotulinum toxin A 750 U for treating neurological detrusor overactivity

B Peyronnet, M Roumiguié, E Castel-Lacanal… - World journal of …, 2016 - Springer
Purpose To assess clinical and urodynamic efficacy of the first and repeated intradetrusor
injections of abobotulinum toxin A (Dysport®, Ipsen®, France) in patients with neurogenic …